Dr. Jake Decker, MD

Claim this profile

Medical College of Wiconsin

Studies Hereditary Hemorrhagic Telangiectasia (HHT)
Studies Telangiectasia
2 reported clinical trials
5 drugs studied

Affiliated Hospitals

Image of trial facility.
Medical College Of Wiconsin
Image of trial facility.
Medical College Of Wisconsin

Clinical Trials Jake Decker, MD is currently running

Image of trial facility.

Combo Diabetes Drug

for Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. To accomplish this objective, we will randomly assign 6,000 patients with established T2D and ASCVD or high-risk for ASCVD in a 1:1 allocation to sodium-glucose cotransporter-2 inhibitor (SGLT2i) or glucagon-like peptide-1 receptor agonists (GLP-1RA). Participants will be followed for the occurrence of the trial primary endpoint of the total (first and recurrent) number of episodes of myocardial infarction (MI), stroke, arterial revascularization, hospitalization for heart failure, development of end-stage kidney disease, kidney transplantation, and mortality, counting all events from randomization until end of study.
Recruiting3 awards Phase 48 criteria

More about Jake Decker, MD

Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Jake Decker, MD has experience with
  • Placebo
  • Pomalidomide
  • Combination Drug
  • GLP-1 Receptor Agonist
  • SGLT2 Inhibitor
Breakdown of trials Jake Decker, MD has run
Hereditary Hemorrhagic Telangiectasia (HHT)
Telangiectasia
Kidney Disease
Diabetic Kidney Disease
Diabetes Mellitus

Other Doctors you might be interested in

Reza Shaker, MDMedical College of Wisconsin
Colleen A. LawtonFroedtert Hospital
Nirav Shah, MDMedical College of Wisconsin

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jake Decker, MD specialize in?
Jake Decker, MD focuses on Hereditary Hemorrhagic Telangiectasia (HHT) and Telangiectasia. In particular, much of their work with Hereditary Hemorrhagic Telangiectasia (HHT) has involved treating patients, or patients who are undergoing treatment.
Is Jake Decker, MD currently recruiting for clinical trials?
Yes, Jake Decker, MD is currently recruiting for 1 clinical trial in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Jake Decker, MD has studied deeply?
Yes, Jake Decker, MD has studied treatments such as Placebo, Pomalidomide, Combination drug.
What is the best way to schedule an appointment with Jake Decker, MD?
Apply for one of the trials that Jake Decker, MD is conducting.
What is the office address of Jake Decker, MD?
The office of Jake Decker, MD is located at: Medical College of Wiconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Medical College of Wiconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top